U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07225686) titled 'Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy' on Nov. 05.
Brief Summary: This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are receiving positive airway pressure (PAP) therapy and are living with overweight or obesity.
Study Start Date: Dec. 17
Study Type: INTERVENTIONAL
Condition:
Obesity
Obstructive Sleep Apnea
Intervention:
DRUG: Maridebart cafraglutide
Participants will receive maridebart cafraglutide...